Banque Cantonale Vaudoise Takes Position in The Allstate Corporation (NYSE:ALL)

Banque Cantonale Vaudoise purchased a new position in shares of The Allstate Corporation (NYSE:ALL - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 11,484 shares of the insurance provider's stock, valued at approximately $2,378,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALL. Rehmann Capital Advisory Group grew its position in shares of Allstate by 3.2% during the 1st quarter. Rehmann Capital Advisory Group now owns 1,630 shares of the insurance provider's stock valued at $338,000 after acquiring an additional 51 shares during the period. Vantage Point Financial LLC lifted its stake in Allstate by 3.6% in the 1st quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider's stock valued at $310,000 after buying an additional 52 shares in the last quarter. Confluence Wealth Services Inc. lifted its stake in Allstate by 0.7% in the 1st quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider's stock valued at $1,558,000 after buying an additional 54 shares in the last quarter. Achmea Investment Management B.V. lifted its stake in Allstate by 0.3% in the 1st quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider's stock valued at $4,262,000 after buying an additional 57 shares in the last quarter. Finally, Avidian Wealth Enterprises LLC lifted its stake in Allstate by 1.7% in the 1st quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider's stock valued at $735,000 after buying an additional 59 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.

Allstate Trading Down 0.8%

Allstate stock traded down $1.61 during trading on Wednesday, hitting $192.29. The company had a trading volume of 1,891,513 shares, compared to its average volume of 1,422,405. The Allstate Corporation has a 1-year low of $168.36 and a 1-year high of $213.18. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.40. The company's 50 day simple moving average is $198.69 and its 200-day simple moving average is $197.01. The stock has a market cap of $50.92 billion, a price-to-earnings ratio of 13.13, a price-to-earnings-growth ratio of 1.01 and a beta of 0.33.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.20 by $2.74. Allstate had a net margin of 6.19% and a return on equity of 24.62%. During the same quarter in the previous year, the company posted $1.61 earnings per share. The company's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be given a dividend of $1.00 per share. The ex-dividend date is Friday, August 29th. This represents a $4.00 annualized dividend and a yield of 2.08%. Allstate's payout ratio is currently 27.32%.

Wall Street Analyst Weigh In

ALL has been the topic of a number of research reports. JPMorgan Chase & Co. raised their price target on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Barclays raised their price target on shares of Allstate from $172.00 to $188.00 and gave the company an "underweight" rating in a research note on Monday, July 7th. BMO Capital Markets reissued an "outperform" rating on shares of Allstate in a research note on Friday, May 16th. Morgan Stanley raised their target price on shares of Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Finally, UBS Group raised their target price on shares of Allstate from $230.00 to $235.00 and gave the stock a "buy" rating in a research note on Wednesday, July 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Allstate currently has a consensus rating of "Moderate Buy" and a consensus target price of $227.07.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.